Two Sigma Advisers’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $57.2M | Sell |
|
|||||
2025
Q1 | $92.7M | Buy |
|
|||||
2024
Q4 | $81.8M | Buy |
|
|||||
2024
Q3 | $82.9M | Buy |
|
|||||
2024
Q2 | $44.6M | Buy |
|
|||||
2024
Q1 | $36.9M | Buy |
|
|||||
2023
Q4 | $10.6M | Sell |
|
|||||
2023
Q3 | $13.6M | Sell |
|
|||||
2023
Q2 | $44.8M | Sell |
|
|||||
2023
Q1 | $83.7M | Sell |
|
|||||
2022
Q4 | $223M | Sell |
|
|||||
2022
Q3 | $234M | Sell |
|
|||||
2022
Q2 | $203M | Sell |
|
|||||
2022
Q1 | $231M | Buy |
|
|||||
2021
Q4 | $109M | Buy |
|
|||||
2021
Q3 | $14.3M | Buy |
|
|||||
2020
Q4 | – | Sell |
|
|||||
2020
Q3 | $2.75M | Sell |
|
|||||
2020
Q2 | $15M | Sell |
|
|||||
2020
Q1 | $27.8M | Sell |
|
|||||
2019
Q4 | $60.3M | Sell |
|
|||||
2019
Q3 | $140M | Buy |
|
|||||
2019
Q2 | $134M | Buy |
|
|||||
2019
Q1 | $16M | Sell |
|
|||||
2018
Q4 | $49.6M | Buy |
|
|||||
2018
Q3 | $12.3M | Buy |
|
|||||
2018
Q2 | $3.22M | Buy |
|
|||||
2018
Q1 | $274K | Buy |
|
|||||
2017
Q2 | – | Sell |
|
|||||
2017
Q1 | $328K | Sell |
|
|||||
2016
Q4 | $126M | Buy |
|
|||||
2016
Q3 | – | Sell |
|
|||||
2016
Q2 | $96M | Buy |
|
|||||
2016
Q1 | $66.9M | Sell |
|
|||||
2015
Q4 | $148M | Buy |
|
|||||
2015
Q3 | $83.6M | Buy |
|
|||||
2015
Q2 | $71.2M | Buy |
|
|||||
2015
Q1 | – | Sell |
|
|||||
2014
Q4 | $57.3M | Buy |
|
|||||
2014
Q3 | $52.6M | Buy |
|
|||||
2014
Q2 | – | Hold |
|
|||||
2014
Q1 | – | Sell |
|
|||||
2013
Q4 | $7.18M | Sell |
|
|||||
2013
Q3 | $18.5M | Buy |
|
|||||
2013
Q2 | $4.64M | Buy |
|